Stroke is one of the most serious cardiovascular events with severe consequences, up to paralysis and death. Patients at high risk of stroke include those with atrial fibrillation; in such patients prevention of stroke is particularly relevant. The article discusses the main issues of efficacy and safety of apixaban for the prevention of stroke in patients with non-valvular atrial fibrillation
BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence ove...
Jerome Ment Department of Cardiology, Birmingham Heartlands Hospital, Birmingham, UK Abstract: Atri...
Item does not contain fulltextBACKGROUND: Vitamin K antagonists are highly effective in preventing s...
OBJECTIVE: The objective of this EBM review is to determine whether or not Apixaban is effective for...
In the article questions of prevention of stroke, including repeated ones, are considered. The choic...
The articles deals with the analysis of clinical situations in patients with atrial fibrillations in...
Adam Ioannou,1 Irene Tsappa,2 Sofia Metaxa,3 Constantinos G Missouris2,3 1Cardiology Department, Roy...
The use of oral anticoagulant therapy for stroke prevention in atrial fibrillation has been transfor...
This drug information question and answer sheet discusses the use of apixaban (Eliquis) for the prim...
Thromboembolic events, principally stroke, represent among the leading causes of morbidity and morta...
The article is a review of literature on the prognosis and prevention of stroke in patients with atr...
Item does not contain fulltextThe only major and potentially fatal risk for patients with atrial fib...
WOS: 000396439000004Atrial fibrillation (AF) is a strong, independent risk factor for stroke. Until ...
Is apixaban effective for the prevention of stroke in patients with non-valvular atrial fibrillation
Atrial fibrillation is a common arrhythmia that increases the risk of stroke and systemic embolism. ...
BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence ove...
Jerome Ment Department of Cardiology, Birmingham Heartlands Hospital, Birmingham, UK Abstract: Atri...
Item does not contain fulltextBACKGROUND: Vitamin K antagonists are highly effective in preventing s...
OBJECTIVE: The objective of this EBM review is to determine whether or not Apixaban is effective for...
In the article questions of prevention of stroke, including repeated ones, are considered. The choic...
The articles deals with the analysis of clinical situations in patients with atrial fibrillations in...
Adam Ioannou,1 Irene Tsappa,2 Sofia Metaxa,3 Constantinos G Missouris2,3 1Cardiology Department, Roy...
The use of oral anticoagulant therapy for stroke prevention in atrial fibrillation has been transfor...
This drug information question and answer sheet discusses the use of apixaban (Eliquis) for the prim...
Thromboembolic events, principally stroke, represent among the leading causes of morbidity and morta...
The article is a review of literature on the prognosis and prevention of stroke in patients with atr...
Item does not contain fulltextThe only major and potentially fatal risk for patients with atrial fib...
WOS: 000396439000004Atrial fibrillation (AF) is a strong, independent risk factor for stroke. Until ...
Is apixaban effective for the prevention of stroke in patients with non-valvular atrial fibrillation
Atrial fibrillation is a common arrhythmia that increases the risk of stroke and systemic embolism. ...
BACKGROUND: Atrial fibrillation (AF) is a common tachyarrhythmia in Australia, with a prevalence ove...
Jerome Ment Department of Cardiology, Birmingham Heartlands Hospital, Birmingham, UK Abstract: Atri...
Item does not contain fulltextBACKGROUND: Vitamin K antagonists are highly effective in preventing s...